After P~review,i would hope with extra news and a push from apple,we break 5 pps in jan,then head to the nasq exchange,and move further higher,with news on parks,and bareburn working on the pain phase,with regards to parks,first patent must be gotten,that alone should push us higher some what,hey if we get PR then evetything goes well,start selling in may,by that time there 75 million sales force should of be well ahead of the game,it comes down to P~ review,if we get it or not,think it's much bigger factor to our pps then we think,imo.with that evetything is on a go,60 70%percent possibility of approvel with that from what i understand on this MB.
It is difficult to say, without knowing the royalty percentages and milestone strata. Hopefully, north of $2.00 running into a Priority Review decision and north of $3.00 on approval. Being so heavily held by retail, the sell-off after an approval will precipitate a decline, although the milestone payment may buoy the price. Like I opened is difficult to say without more knowledge of the partnership deal. GLTA!
I think we get fast track and approved in 2013. We may spike above $3 and then fall a bit until sales start. Unless we can get some trial news on other applications (pain, Parkinson's ). I think we at least begin relisting..... or bought out. Happy new year's everyone!